https://stock.noler.com/us/stock/immage-biotherapeutics-corp https://stock.noler.com/us/stock/immage-biotherapeutics-corp/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/immage-biotherapeutics-corp/accumulated-depreciation https://stock.noler.com/us/stock/immage-biotherapeutics-corp/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/immage-biotherapeutics-corp/amortization https://stock.noler.com/us/stock/immage-biotherapeutics-corp/buybacks-share-repurchases https://stock.noler.com/us/stock/immage-biotherapeutics-corp/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/immage-biotherapeutics-corp/capital-expenditures https://stock.noler.com/us/stock/immage-biotherapeutics-corp/cash https://stock.noler.com/us/stock/immage-biotherapeutics-corp/cash-and-equivalents https://stock.noler.com/us/stock/immage-biotherapeutics-corp/cash-flow-breakdown https://stock.noler.com/us/stock/immage-biotherapeutics-corp/common-stock-other-shares-outstanding https://stock.noler.com/us/stock/immage-biotherapeutics-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/immage-biotherapeutics-corp/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/immage-biotherapeutics-corp/common-stock-shares-subscribed-but-unissued https://stock.noler.com/us/stock/immage-biotherapeutics-corp/common-stock-shares-subscriptions https://stock.noler.com/us/stock/immage-biotherapeutics-corp/common-stock-value https://stock.noler.com/us/stock/immage-biotherapeutics-corp/costs-and-expenses https://stock.noler.com/us/stock/immage-biotherapeutics-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/immage-biotherapeutics-corp/current-assets https://stock.noler.com/us/stock/immage-biotherapeutics-corp/current-liabilities https://stock.noler.com/us/stock/immage-biotherapeutics-corp/deferred-tax-assets-gross https://stock.noler.com/us/stock/immage-biotherapeutics-corp/deferred-tax-assets-net https://stock.noler.com/us/stock/immage-biotherapeutics-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/immage-biotherapeutics-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/immage-biotherapeutics-corp/depreciation https://stock.noler.com/us/stock/immage-biotherapeutics-corp/depreciation-amortization-and-accretion-net https://stock.noler.com/us/stock/immage-biotherapeutics-corp/depreciation-and-amortization https://stock.noler.com/us/stock/immage-biotherapeutics-corp/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/immage-biotherapeutics-corp/due-to-related-parties-current https://stock.noler.com/us/stock/immage-biotherapeutics-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/immage-biotherapeutics-corp/financing-cash-flow https://stock.noler.com/us/stock/immage-biotherapeutics-corp/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/immage-biotherapeutics-corp/general-and-administrative-expense https://stock.noler.com/us/stock/immage-biotherapeutics-corp/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/immage-biotherapeutics-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/immage-biotherapeutics-corp/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/immage-biotherapeutics-corp/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/immage-biotherapeutics-corp/increase-decrease-in-notes-payable-related-parties https://stock.noler.com/us/stock/immage-biotherapeutics-corp/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/immage-biotherapeutics-corp/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/immage-biotherapeutics-corp/interest-expense https://stock.noler.com/us/stock/immage-biotherapeutics-corp/interest-payable-current https://stock.noler.com/us/stock/immage-biotherapeutics-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/immage-biotherapeutics-corp/net-cash-from-investing-activities https://stock.noler.com/us/stock/immage-biotherapeutics-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/immage-biotherapeutics-corp/net-change-in-cash https://stock.noler.com/us/stock/immage-biotherapeutics-corp/net-income https://stock.noler.com/us/stock/immage-biotherapeutics-corp/new-shares-sold https://stock.noler.com/us/stock/immage-biotherapeutics-corp/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/immage-biotherapeutics-corp/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/immage-biotherapeutics-corp/operating-cash-flow https://stock.noler.com/us/stock/immage-biotherapeutics-corp/operating-expenses https://stock.noler.com/us/stock/immage-biotherapeutics-corp/operating-income https://stock.noler.com/us/stock/immage-biotherapeutics-corp/operating-loss-carryforwards https://stock.noler.com/us/stock/immage-biotherapeutics-corp/other-nonoperating-income-expense https://stock.noler.com/us/stock/immage-biotherapeutics-corp/other-short-term-borrowings https://stock.noler.com/us/stock/immage-biotherapeutics-corp/payments-for-rent https://stock.noler.com/us/stock/immage-biotherapeutics-corp/payments-to-fund-longterm-loans-to-related-parties https://stock.noler.com/us/stock/immage-biotherapeutics-corp/prepaid-expense-current https://stock.noler.com/us/stock/immage-biotherapeutics-corp/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/immage-biotherapeutics-corp/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/immage-biotherapeutics-corp/proceeds-from-notes-payable https://stock.noler.com/us/stock/immage-biotherapeutics-corp/proceeds-from-related-party-debt https://stock.noler.com/us/stock/immage-biotherapeutics-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/immage-biotherapeutics-corp/professional-fees https://stock.noler.com/us/stock/immage-biotherapeutics-corp/profit-loss https://stock.noler.com/us/stock/immage-biotherapeutics-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/immage-biotherapeutics-corp/property-plant-equipment https://stock.noler.com/us/stock/immage-biotherapeutics-corp/public-float https://stock.noler.com/us/stock/immage-biotherapeutics-corp/repayment-of-notes-receivable-from-related-parties https://stock.noler.com/us/stock/immage-biotherapeutics-corp/repayments-of-related-party-debt https://stock.noler.com/us/stock/immage-biotherapeutics-corp/research-and-development https://stock.noler.com/us/stock/immage-biotherapeutics-corp/retained-earnings https://stock.noler.com/us/stock/immage-biotherapeutics-corp/sga-expense https://stock.noler.com/us/stock/immage-biotherapeutics-corp/shareholders-equity https://stock.noler.com/us/stock/immage-biotherapeutics-corp/shares-authorized https://stock.noler.com/us/stock/immage-biotherapeutics-corp/shares-issued https://stock.noler.com/us/stock/immage-biotherapeutics-corp/shares-issued-for-acquisitions https://stock.noler.com/us/stock/immage-biotherapeutics-corp/shares-issued-price-per-share https://stock.noler.com/us/stock/immage-biotherapeutics-corp/shares-issued-shares-new-issues https://stock.noler.com/us/stock/immage-biotherapeutics-corp/shares-repurchased https://stock.noler.com/us/stock/immage-biotherapeutics-corp/short-term-borrowings https://stock.noler.com/us/stock/immage-biotherapeutics-corp/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/immage-biotherapeutics-corp/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/immage-biotherapeutics-corp/stock-split-ratio https://stock.noler.com/us/stock/immage-biotherapeutics-corp/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/immage-biotherapeutics-corp/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/immage-biotherapeutics-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/immage-biotherapeutics-corp/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/immage-biotherapeutics-corp/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/immage-biotherapeutics-corp/total-assets https://stock.noler.com/us/stock/immage-biotherapeutics-corp/total-liabilities https://stock.noler.com/us/stock/immage-biotherapeutics-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/immage-biotherapeutics-corp/value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/immage-biotherapeutics-corp/weighted-average-number-of-share-outstanding-basic-and-diluted